Zevra Therapeutics, Inc. ZVRA Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashExpense.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s other working capital?
- Zevra Therapeutics, Inc. (ZVRA) reported other working capital of $341K in Q1 2026.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.